The reconstructed cranium of Pierolapithecus and the evolution of the great ape face.

Pierolapithecus catalaunicus (~12 million years ago, northeastern Spain) is key to understanding the mosaic nature of hominid (great ape and human) evolution. Notably, its skeleton indicates that an orthograde (upright) body plan preceded suspensory adaptations in hominid evolution. However, there is ongoing debate about this species, partly because the sole known cranium, preserving a nearly complete face, suffers from taphonomic damage. We 1) carried out a micro computerized tomography (CT) based virtual reconstruction of the Pierolapithecus cranium, 2) assessed its morphological affinities using a series of two-dimensional (2D) and three-dimensional (3D) morphometric analyses, and 3) modeled the evolution of key aspects of ape face form. The reconstruction clarifies many aspects of the facial morphology of Pierolapithecus. Our results indicate that it is most similar to great apes (fossil and extant) in overall face shape and size and is morphologically distinct from other Middle Miocene apes. Crown great apes can be distinguished from other taxa in several facial metrics (e.g., low midfacial prognathism, relatively tall faces) and only some of these features are found in Pierolapithecus, which is most consistent with a stem (basal) hominid position. The inferred morphology at all ancestral nodes within the hominoid (ape and human) tree is closer to great apes than to hylobatids (gibbons and siamangs), which are convergent with other smaller anthropoids. Our analyses support a hominid ancestor that was distinct from all extant and fossil hominids in overall facial shape and shared many features with Pierolapithecus. This reconstructed ancestral morphotype represents a testable hypothesis that can be reevaluated as new fossils are discovered.

Diverse task-driven modeling of macaque V4 reveals functional specialization towards semantic tasks.

Responses to natural stimuli in area V4-a mid-level area of the visual ventral stream-are well predicted by features from convolutional neural networks (CNNs) trained on image classification. This result has been taken as evidence for the functional role of V4 in object classification. However, we currently do not know if and to what extent V4 plays a role in solving other computational objectives. Here, we investigated normative accounts of V4 (and V1 for comparison) by predicting macaque single-neuron responses to natural images from the representations extracted by 23 CNNs trained on different computer vision tasks including semantic, geometric, 2D, and 3D types of tasks. We found that V4 was best predicted by semantic classification features and exhibited high task selectivity, while the choice of task was less consequential to V1 performance. Consistent with traditional characterizations of V4 function that show its high-dimensional tuning to various 2D and 3D stimulus directions, we found that diverse non-semantic tasks explained aspects of V4 function that are not captured by individual semantic tasks. Nevertheless, jointly considering the features of a pair of semantic classification tasks was sufficient to yield one of our top V4 models, solidifying V4's main functional role in semantic processing and suggesting that V4's selectivity to 2D or 3D stimulus properties found by electrophysiologists can result from semantic functional goals.

Does Wound VAC Temporization Offer Patient-Reported Outcomes Similar to Single-Stage Excision Reconstruction After Myxofibrosarcoma Resection?

BACKGROUND: Vacuum-assisted closure (VAC) temporization is a promising technique to achieve local control in aggressive soft tissue sarcomas. Despite its previously reported efficacy, adoption of VAC temporization remains limited, primarily due to the scarce literature on patient-reported outcomes (PROs) supporting its efficacy. This study compared the postoperative PROs after VAC temporization or single-stage (SS) excision and reconstruction for patients undergoing surgical resection for myxofibrosarcoma management. METHODS: A retrospective analysis of myxofibrosarcoma patients who underwent surgical resections at our institution from 2016 to 2022 was performed. Postoperative PROs collected prospectively for those treated with VAC temporization or SS excision/reconstruction were compared using a visual analog scale (VAS) for pain and three Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires: Global Health Short-Form Mental (SF Mental), Global Health Short-Form Physical (SF Physical), and Physical Function Short-Form 10a (SF 10a). Absolute and differential (postoperative minus preoperative) scores at the 1-month, 3-month, 6-month, 1-year, and 2-year time points were compared. RESULTS: The analysis included 79 patients (47 treated with VAC temporization and 32 treated with SS excision/reconstruction). All outcomes were similar between the groups except for physical function 1 year after surgery, in which the differential PROMIS SF 10a scores were higher in the SS group (p = 0.001). All the remaining absolute and differential PROMIS and VAS pain scores were similar between the groups at all time points. Postoperative complications did not differ between the groups. CONCLUSION: The PROs for physical and mental health, physical function, and pain were similar between the myxofibrosarcoma patients who had VAC temporization and those who had SS excision/reconstruction after surgical resection.

Risk factors for local recurrence of upper extremity desmoid tumors.

INTRODUCTION: Upper extremity (UE) desmoid tumors are locally aggressive neoplasms with high recurrence rates. Our study sought to analyze the demographics and treatment strategies of UE desmoid tumors and identify risk factors for recurrence. MATERIALS AND METHODS: A retrospective review of 52 patients with histologically confirmed UE desmoid tumors treated at our institution between 1990 and 2015 was conducted. Survival was assessed using the Kaplan-Meier method and the Cox proportional hazards model was used for risk factor analysis. RESULTS: For the entire cohort, median age was 40 (29-47) years, 75% were female, and 48% had local recurrence. The median tumor size was 45 (15-111) cm3 on imaging. Twenty-two patients had a previous resection. The most common treatments were surgery alone (50%) and surgery with adjuvant radiotherapy (21%). Tumor size ≥5 cm and tumor volume ≥40 cm3 on imaging were associated with increased recurrence (p = 0.006 and p = 0.005, respectively). Age and sex were not associated with local recurrence. Patients with a tumor size ≥5 cm were 2.6 times more likely to present with recurrence. At the 10-year mark, a lower local recurrence-free survival was seen in patients with tumors ≥5 cm (72.2% vs. 36.3%, p = 0.042) or ≥40 cm3 (67.2% vs. 32.7%, p = 0.034). CONCLUSION: In our study, only tumor dimensions appeared to modify recurrence risk.

Prediction of 5-year survival in soft tissue leiomyosarcoma using a machine learning model algorithm.

BACKGROUND AND OBJECTIVES: Leiomyosarcoma (LMS) is associated with one of the poorest overall survivals among soft tissue sarcomas. We sought to develop and externally validate a model for 5-year survival prediction in patients with appendicular or truncal LMS using machine learning algorithms. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was used for development and internal validation of the models; external validation was assessed using our institutional database. Five machine learning algorithms were developed and then tested on our institutional database. Area under the receiver operating characteristic curve (AUC) and Brier score were used to assess model performance. RESULTS: A total of 2209 patients from the SEER database and 81 patients from our tertiary institution were included. All models had excellent calibration with AUC 0.84-0.85 and Brier score 0.15-0.16. After assessing the performance indicators according to the TRIPOD model, we found that the Elastic-Net Penalized Logistic Regression outperformed other models. The AUCs of the institutional data were 0.83 (imputed) and 0.85 (complete-case analysis) with a Brier score of 0.16. CONCLUSION: Our study successfully developed five machine learning algorithms to assess 5-year survival in patients with LMS. The Elastic-Net Penalized Logistic Regression retained performance upon external validation with an AUC of 0.85 and Brier score of 0.15.

Wound vacuum-assisted closure temporization after tumor resection of soft tissue sarcomas-A cost analysis in a propensity-score matched population.

BACKGROUND: Vacuum-assisted closure (VAC) temporization is a technique associated with high local control rates used in myxofibrosarcoma. We sought to compare the costs and postoperative outcomes of VAC temporization and single-stage (SS) excision/reconstruction. METHODS: We conducted a retrospective analysis of patients with myxofibrosarcoma surgically treated at our institution between 2000 and 2022. Variables of interest included total, direct, and indirect costs for initial episode of care, 90 days and 1 year after initial admission, and postoperative outcomes. Costs were compared between the VAC temporization and SS groups. RESULTS: After matching, 13 patients in the SS group and 23 in the VAC group were analyzed. We found no difference in median and mean total inpatient costs, between the VAC temporization and SS group. While total 90-day and 1-year costs were higher in the VAC group compared to the SS group, mean costs were similar. There were no differences in postoperative complications between groups. A subanalysis of the entire cohort (n = 139) revealed lower local recurrence and overall death rates in the VAC temporization group. CONCLUSION: VAC temporization had similar inpatient costs and postoperative outcomes to SS excision/reconstruction. While median 90-day and 1-year costs were higher in the VAC group, mean costs did not differ.

Study of restricted diffusion of lithium salts in diglyme confined in mesoporous carbons as a model for cathodes in lithium-air batteries.

The Li+ ion mobility through the porous cathode is a critical aspect in the development of commercial Li-air batteries. The bulk transport properties of lithium salts in organic solvents are not reliable parameters for the design of this type of battery since confinement could significantly modify the transport properties, especially when pore diameters are below 10 nm. In this work, we studied the effect of the carbon mesostructure and surface charge on the diffusion of LiTf and LiTFSI salts dissolved in diglyme, typical electrolytes for lithium-air batteries. Interdiffusion coefficients of the salts were determined using a conductimetric method. NMR spectroscopy and relaxometry were used to explore the effect of the carbon structure and the surface charge density on the interaction between the electrolytes and the pore wall. We showed that carbon micro/mesoporous structure plays a critical role in the transport properties of the electrolyte, producing a decrease of up to 2-3 orders of magnitude in the salt interdiffusion coefficients when going from bulk solutions to pores below 4 nm in diameter. It was observed that for pores 25 nm in diameter, the reduction in the diffusion coefficient can be mainly ascribed to the porosity of the sample, giving tortuosity factors around 1. However, for smaller pore sizes (1-10 nm diameter) bigger tortuosity coefficients were observed and were related to strong ion-pore wall interactions. Moreover, it was noticed that the ratio between the diffusion coefficients of the two studied salts dissolved in diglyme, is different in bulk and under confinement, demonstrating that the interactions of the ions with the charged pore wall probably compete with the cation-anion interactions, affecting salt association under confinement.

Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution.

BACKGROUND: Phosphaturic mesenchymal tumor (PMT) is a rare tumor that causes tumor-induced osteomalacia. Patients present with non-specific symptoms secondary to renal phosphate wasting and decreased bone mineralization. We sought to assess: (1) What are the common presenting features, laboratory and imaging findings, histologic findings of phosphaturic mesenchymal tumors? (2) What are the available treatment strategies for phosphaturic mesenchymal tumors and their long-term outcomes in terms of local recurrence and symptom control after treatment? METHODS: We retrospectively identified patients with a histologic diagnosis of PMT located in the axial or appendicular skeleton, or surrounding soft tissues. A total of 10 patients were finally included in our study. RESULTS: Median tumor size was 1.9 cm (range, 1.1 to 6.1) and median time from symptom onset to diagnosis was 3 years (range, 0.5 to 15 years). All patients but one presented with hypophosphatemia (median 1.9 mg/dL, range 1.2 to 3.2). Pre-operative FGF-23 was elevated in all cases (median 423.5 RU/mL, range 235 to 8950). Six patients underwent surgical resection, three were treated percutaneously (radiofrequency ablation or cryoablation), and one refused treatment. Only one patient developed local recurrence and no patients developed metastatic disease. At last follow-up, nine patients showed no evidence of disease and one was alive with disease. CONCLUSION: Phosphaturic mesenchymal tumor is a rare tumor presenting with non-specific symptoms. Surgery is the standard treatment when negative margins can be achieved without significant morbidity. In patients with small tumors in surgically-inaccessible areas, radiofrequency ablation or cryoablation can be performed successfully.

Running Critical Power and W´: Influence of the Environment, Timing and Time Trial Order.

This study aimed to determine the influence of the testing environment (track vs. treadmill), time trial order (long-short vs. short-long), and timing (within-session vs. between-sessions) on the critical power (CP) and work over CP (W´), using the power metric in runners. Fifteen highly trained athletes performed three test sessions composed of two time trials of 9- and 3-min, separated by a 30-min rest period. One session was performed on a track, and two sessions on a treadmill, alternating the order of the time trials. The CP and W´ values determined on the track were significantly greater and lower than on the treadmill, respectively (p<0.001; CP≥89 W; W´≥3.7 kJ). Their degree of agreement was low (SEE CP>5%; W´>10%) and therefore was not interchangeable. There were no performance differences in the timing of the time trials (p=0.320). Lastly, performing the 9-min trial first resulted in a greater power output compared to when executed last (p<0.001; 4.9 W), although this resulted in similar CP and W´ values (Bias<5 and 10%, respectively). In conclusion, it is feasible to test CP and W´ in a single testing session, irrespective of the time trial order, although not interchangeably between track and treadmill.

Running Functional Threshold versus Critical Power: Same Concept but Different Values.

The aims of this study were (i) to estimate the functional threshold power (FTP) and critical power (CP) from single shorter time trials (TTs) (i. e. 10, 20 and 30 minutes) and (ii) to assess their location in the power-duration curve. Fifteen highly trained athletes randomly performed ten TTs (i. e. 1, 2, 3, 4, 5, 10, 20, 30, 50 and 60 minutes). FTP was determined as the mean power output developed in the 60-min TT, while CP was estimated in the running power meter platform according to the manufacturer's recommendations. The linear regression analysis revealed an acceptable FTP estimate for the 10, 20 and 30-min TTs (SEE≤12.27 W) corresponding to a correction factor of 85, 90 and 95%, respectively. An acceptable CP estimate was only observed for the 20-min TT (SEE=6.67 W) corresponding to a correction factor of 95%. The CP was located at the 30-min power output (1.0 [-5.1 to 7.1] W), which was over FTP (14 [7.0 to 21] W). Therefore, athletes and practitioners concerned with determining FTP and CP through a feasible testing protocol are encouraged to perform a 20-min TT and apply a correction factor of 90 and 95%, respectively.

The Variability of the Components of Fitness along the Menstrual Cycle.

This study aims to determine the variability of the components of fitness along the menstrual cycle (MC) of physically active eumenorrheic women. Fifteen subjects were monitored along two consecutive MCs through the calendar-based counting method in combination with a urine luteinizing hormone surge kit. Subjects were tested at the early follicular phase (EFP), pre-ovulatory or late follicular phase (LFP), and post-ovulatory or mid-luteal phase (MLP). In each session, the back squat one-repetition maximum (1-RM), maximum fat oxidation (MFO), maximum oxygen uptake (VO2max) and acute recovery capacity were determined. The results revealed a wide variability among components of fitness and a low to high variability among subjects (acute recovery: 3.6% [range 1.5 to 9.5%]; back squat 1-RM: 6.1% [range 2.2 to 11%]; VO2max: 6.6% [range 1.1 to 15%]; MFO: 23% [range 4.6 to 35%]). Despite the individual nature, considering the number and magnitude of the responses in each MC phase, VO2max and acute recovery capacity tended to be enhanced at the LFP, the MFO at the MLP, and the back squat 1-RM remained stable along the MC. Thus, practitioners are aware of which components are susceptible to change along the MC phase, but an individual monitoring is recommended.

Reconstruction of the elbow with distal humerus endoprosthetic replacement after tumor resection: a systematic review of the literature and institutional case series.

BACKGROUND: Distal humerus replacement (DHR) is a modular endoprosthesis mainly used for bone reconstruction after resection of primary or metastatic bone lesions. Studies on DHR failure rates and postoperative functional outcomes are scarce. We sought to assess implant survival, modes of failure, and functional outcomes in patients undergoing DHR for oncologic indications. METHODS: A systematic review of the PubMed and Embase databases was performed. PRISMA guidelines were followed for this manuscript. Our study was registered on PROSPERO (457,260). Quality appraisal of included studies was conducted using the STROBE checklist. Prosthetic failure was assessed using the Henderson classification for megaprosthetic failures. We additionally performed a retrospective review of patients treated with a DHR for oncologic indications at a large tertiary care academic center. Weighted means were calculated to pool data. RESULTS: Eleven studies with a total of 162 patients met the inclusion criteria. Mean follow-up was 3.7 years (range, 1.66-8 years). Henderson type 2 failures (aseptic loosening) were the most common mode of failure, occurring in 12% of cases (range, 0%-33%). Five-year implant survival was 72% (range, 49%-93.7%). Mean postoperative Musculoskeletal Tumor Society (MSTS) score was 81.1 (range, 74-84.3). In our institutional case series, 2 out of 5 patients had DHR revision for periprosthetic fracture and aseptic loosening at 16 and 27 months after surgery, respectively. CONCLUSIONS: Distal humerus replacement is a successful reconstruction strategy for tumors of the distal humerus, with high implant survival and good to excellent functional outcomes.

Complications and functional outcomes after reconstruction of the proximal humerus with allograft-prosthetic composite: a systematic review of the literature.

BACKGROUND: Allograft prosthetic composite (APC) reconstruction is performed after resection of proximal humerus tumors or failure of arthroplasty implants. There is limited literature on the postoperative outcomes of this technique. We sought to assess implant survival, failure rates, and postoperative functional outcomes after APC reconstruction of the proximal humerus. METHODS: A systematic review of the PubMed and Embase databases was conducted. The study was registered on PROSPERO (ID: 448,663). The Strengthening of the Reporting of Observational Studies in Epidemiology checklist was used for quality assessment. Implant failure was determined using the Henderson classification for biological reconstruction. Functional outcome was primarily assessed using the Musculoskeletal Tumor Society score at last follow-up. RESULTS: Twenty-five studies with a total of 488 patients were included. Mean follow-up in reporting studies ranged from 2.5 to 10 years. Five-year revision-free survival for implants ranged from 41% to 92%. Overall implant failure rate ranged from 9% to 54%, and reoperation rate ranged from 0% to 55%. Graft host nonunion (type 2) was the most common mode of failure, with rates ranging from 0% to 75%. The mean Musculoskeletal Tumor Society scores at last follow-up ranged from 57% to 90% across studies. A trend towards better functional outcomes was seen in patients having an APC with a reverse total shoulder arthroplasty (rTSA) compared with those with hemiarthroplasty. CONCLUSIONS: APCs show promise in proximal shoulder reconstruction, with heterogeneous functional outcomes that are noninferior to other reconstruction techniques. Graft host nonunion is a common mode of failure and remains a concern in this type of prosthesis. Future studies should compare rTSA-APCs and rTSA endoprostheses while controlling for potential confounders.

Debridement, Antibiotics, and Implant Retention (DAIR) Plus Offers Similar Periprosthetic Joint Infection Treatment Success Rates to Two-Stage Revision in Oncologic Megaprosthesis.

BACKGROUND: Prosthetic joint infections (PJIs) after megaprosthesis implantation are associated with high rates of treatment failure and amputation. Our study analyzed PJI treatment success rates by surgical strategy and assessed risks of reinfection and amputation. METHODS: We retrospectively analyzed the outcomes of patients diagnosed with PJI after undergoing megaprosthesis implantation for oncologic indications. The 2011 Musculoskeletal Infection Society criteria were used to define PJI. Reinfection, reoperation, and amputation for PJI recurrence were assessed. A total of 67 patients with megaprosthesis PJIs were included. There were fourteen patients who were treated with debridement, antibiotics, and implant retention (DAIR), 31 with DAIR plus (DAIR with modular component exchange and stem retention), and 21 with two-stage revisions. Kaplan-Meier estimates were used for survival analyses and Cox proportional hazards for risk factor analyses. RESULTS: The two-year reinfection-free survival was 25% for DAIR and 60% for DAIR plus or two-stage revision (P = .049). The five-year amputation-free survival was 84% for DAIR plus or two-stage revision, and 48% for DAIR (P = .13). Reinfection-free, reoperation-free, and amputation-free survival were similar between DAIR plus and two-stage revision at the 2- and 5-year marks. Body mass index ≥30 (hazard ratio [HR] = 2.65) and chronic kidney disease (HR = 11.53) were risk factors for reinfection. Treatment with DAIR plus or two-stage revision (HR = 0.44) was a protective factor against reinfection. CONCLUSIONS: A DAIR was associated with high rates of treatment failure and higher amputation rates than DAIR plus or 2-stage surgery. A DAIR plus was not inferior to 2-stage revision clearing a PJI and might be performed in patients who cannot withstand two-stage revision surgery.

Life-history traits of an exploited skate: The short-tail yellownose skate Zearaja brevicaudata (Chondrichthyes: Rajiformes).

The short-tail yellownose skate, Zearaja brevicaudata, occurs off southern Brazil and along the Argentine continental shelf, including waters surrounding the Islas Malvinas and the upper slope, and is very frequently caught by trawl fisheries throughout its range. The age, growth, and maturity of Z. brevicaudata were investigated using 204 individuals collected by commercial fishing vessels from northern Argentina, between March 2016 and September 2019. Age was determined on a sample comprising vertebrae from 151 individuals, 60 males, ranging in size from 391 to 956 mm total length (TL), and 91 females, ranging in size from 324 to 1060 mm TL. Maximum ages determined for males and females were 22 and 29 years, respectively. A Bayesian framework was employed with a set of three candidate models to estimate growth parameters (von Bertalanffy, Gompertz, and Logistic). The von Bertalanffy model had the best fit, and the sexes showed undistinguishable growth parameters. For sexes combined, derived growth mean parameters (± S.D.) were L∞ = 1081 mm ± 64.34 mm, k = 0.09 ± 0.01 years-1, and L0 = 248 mm ± 23.52 mm. The age at maturity was estimated at 13.15 and 14.66 years for males and females, respectively.

Can We Predict Long-Duration Running Power Output? Validity of the Critical Power, Power Law, and Logarithmic Models.

ABSTRACT: Ruiz-Alias, SA, Ñancupil-Andrade, AA, Pérez-Castilla, A, and García-Pinillos, F. Can we predict long-duration running power output? Validity of the critical power, power law, and logarithmic models. J Strength Cond Res 38(2): 306-310, 2024-Predicting long-distance running performance has always been a challenge for athletes and practitioners. To ease this task, different empirical models have been proposed to model the drop of the running work rate with the increase of time. Therefore, this study aims to determine the validity of different models (i.e., CP, power law, and Peronnet) to predict long-duration running power output (i.e., 30 and 60 minutes). In a 4-week training period, 15 highly trained athletes performed 7-time trials (i.e., 3, 4, 5, 10, 20, 30, and 60 minutes) in a randomized order. Then, their power-duration curves (PDCs) were defined through the work-time critical power model (CP work ), power-1/time (CP 1/time ), 2-parameter hyperbolic (CP 2hyp ), 3-parameter hyperbolic (CP 3hyp ), the undisclosed Stryd (CP stryd ), and Golden Cheetah (CP cheetah ) proprietary models, and the power law and Peronnet models using the 3 to 20 minutes time trials. These ones were extrapolated to the 30- and 60-minute power output and compared with the actual performance. The CP 2hyp , CP 3hyp , CP stryd , and CP cheetah provided valid 30- and 60-minute power output estimations (≤2.6%). The CP work and CP 1/time presented a large predicting error for 30 minutes (≥4.4%), which increased for 60 minutes (≥8.1%). The power law and Peronnet models progressively increased their predicting error at the longest duration (30 minutes: ≤-1.6%; 60 minutes: ≤-6.6%), which was conditioned by the endurance capability of the athletes. Therefore, athletes and practitioners are encouraged to applicate the aforementioned valid models to their PDC to estimate the 30-minute and 60-minute power output.

Inter-Repetition Rest Impact on the Estimated Repetitions in Reserve at Various Loads and Proximities to Neuromuscular Failure.

ABSTRACT: Ruiz-Alias, SA, Ramirez-Campillo, R, Leando Quidel-Catrilelbún, ME, García-Pinillos, F, and Pérez-Castilla, A. Inter-repetition rest impact on the estimated repetitions in reserve at various loads and proximities to neuromuscular failure . J Strength Cond Res 38(8): 1379-1385, 2024-The repetitions in reserve (RIR) estimation method allows for monitoring resistance training set volume. However, a significant bias is commonly observed when ending the set further from neuromuscular failure and using lower relative loads. Is unclear if implementing an IRR could improve its estimation validity. This study aimed to determine if the RIR estimation is influenced by the IRR at different relative loads and proximities to neuromuscular failure during the back squat (BQ) and bench press (BP) exercises. After a familiarization session, 19 male subjects (age, 21-26 years) completed an experimental session for each IRR configuration: IRR0 (without rest), IRR3 (3 seconds of rest), and SSIRR (self-selected rest [up to 5 seconds]). In each session, single sets to neuromuscular failure were performed at 3 relative loads (65% 1 repetition maximum [1RM], 75% 1RM, 85% 1RM) for BQ and BP exercises. Using the Estimated Repetitions to Failure scale, subjects estimated the RIR associated with a score of "5" and "2" (i.e., RIR-5 and RIR-2). The results revealed no interactions between the RIR estimation and IRR for BQ (RIR-5: p = 0.812; RIR-2: p = 0.084) or BP (RIR-5: p = 0.884; RIR-2: p = 0.944). Subjects provided valid estimations, with overestimation (BQ RIR-5: 0%; BQ RIR-2: 2.9%; BP RIR-5: 1.1%; BP RIR-2: 2.3%) or underestimation (BQ RIR-5: 14.9%; BQ RIR-2: 4%; BP RIR-5: 15.2% BP RIR-2: 8.2%) in few sets. In conclusion, the RIR estimation method seems valid, and the IRR (0-5 seconds) does not influence its validity at 65-85% 1RM loads nor proximities to neuromuscular failure (RIR-2, RIR-5).

Acute Effect of Different Velocity-Based Training Protocols on 2000-meter Rowing Ergometer Performance.

ABSTRACT: Leandro Quidel-Catrilelbún, ME, Ruiz-Alias, SA, García-Pinillos, F, Ramirez-Campillo, R, and Pérez-Castilla, A. Acute effect of different velocity-based training protocols on 2000-m rowing ergometer performance. J Strength Cond Res 38(1): e8-e15, 2024-This study aimed to explore the acute effect of 4 velocity-based resistance training (VBT) protocols on 2000-m rowing ergometer (RE2000) time trial, as well as the behavior of the maximal neuromuscular capacities when RE2000 is performed alone or preceded by VBT protocols in the same session. Fifteen male competitive rowers (15-22 years) undertook 5 randomized protocols in separate occasions: (a) RE2000 alone (control condition); (b) VBT against 60% of 1 repetition maximum (1RM) with a velocity loss in the set of 10% followed by RE2000 (VBT60-10 + RE2000); (c) VBT against 60% 1RM with a velocity loss in the set of 30% followed by RE2000 (VBT60-30 + RE2000); (d) VBT against 80% 1RM with a velocity loss in the set of 10% followed by RE2000 (VBT80-10 + RE2000); (e) VBT against 80% 1RM with a velocity loss in the set of 30% followed by RE2000 (VBT80-30 + RE2000). The load-velocity relationship (load-axis intercept [L0], velocity-axis intercept [v0], and area under the load-velocity relationship line [Aline]) was used to evaluate the maximal neuromuscular capacities during the prone bench pull exercise before and after each protocol. The time trial was significantly longer for VBT60-30 + RE2000 and VBT80-30 + RE2000 than for RE2000, VBT60-10 + RE2000 and VBT80-10 + RE2000 (all p < 0.001; ES = 0.10-0.15). L0 and Aline were significantly reduced after all protocols (p < 0.001; ES = 0.10-0.13), with Aline reduction more accentuated for VBT60-10 + RE2000, VBT60-30 + RE2000, VBT80-30 + RE2000, and RE2000 (all p = 0.001; ES = 0.11-0.18) than for VBT80-10 + RE2000 (p = 0.065; ES = 0.05). Therefore, VBT protocols with greater velocity loss in the set (30% vs. 10%) negatively affected subsequent rowing ergometer performance, in line with impairment in Aline pulling performance.

Humanistic and Economic Burden of Atopic Dermatitis in Pediatric Patients in Spain: A Systematic Review.

Atopic dermatitis (AD) is a chronic, inflammatory skin disease affecting all age groups, particularly children. This systematic review provides an overview of the humanistic and economic disease burden in the pediatric population with AD in Spain. The evidence, collected from 11 observational studies published over the past 10 years, exhibits the most common characteristics of the patients, disease burden, patient-reported outcomes, use of resources, and treatment patterns. The burden of AD extends beyond physical symptoms, with associated comorbidities such as asthma and impaired health-related quality of life and mental health disorders, particularly in severe cases. Traditional therapies, primarily topical corticosteroids, face adherence and efficacy challenges. Despite promising innovative treatments and available biological therapies, their use is still limited in the pediatric population. The findings of the present review highlight the scarce scientific evidence on the economic burden of pediatric AD, as well as the most updated humanistic evidence on this disease. At the same time, the need for individualized care and innovative therapeutic interventions to address the multifaceted challenges of pediatric AD in Spain is evident.

Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort.

BACKGROUND: Functional impairment is the main consideration when it comes to choosing therapy for infantile hemangiomas (IH). However, since most hemangiomas are treated for cosmetic reasons, it is important to know the cosmetic outcome assessed by the parents. OBJECTIVE: To evaluate the aesthetic outcomes of IH, considering the characteristics of the lesions and the treatments used. PATIENTS AND METHODS: The Spanish Infantile Hemangioma Nationwide Prospective Cohort (2016-2022) recruited all consecutive patients diagnosed with IH in 12 Spanish hospitals. The children included had two photos of the IH lesion (at both baseline and at the end of the study). A panel of parents blindly assessed all available photos using a scale from 0 (worst cosmetic outcomes) to 10 (best cosmetic outcomes). The different scores - both before and after treatment - as well as the outcomes percent considered excellent (>9) were described and compared. We analyzed the effect of receiving different therapies and performed causal model analyses estimating the mean treatment effect of parents' assessments. RESULTS: The median follow-up was 3.1 years. A total of 824 photos were evaluated. Baseline aesthetic impact was higher in the propranolol group vs the topical timolol and observation treatment groups (1.85 vs 3.14 vs 3.66 respectively; p<0.001). After treatment, the aesthetic impact was similar between both treatment groups (7.59 vs 7.93 vs 7.90; p>0.2). The causal model could only be applied to the comparison between topical timolol and observation, revealing no differences whatsoever. CONCLUSION: This is the first prospective cohort to analyze the aesthetic outcome of IH. The final aesthetic results of the three therapies were similar, with nearly 40% of patients achieving excellent aesthetic outcomes.